Asoprisnil
Encyclopedia
Asoprisnil is an investigational selective progesterone receptor modulator
developed by Schering
and TAP Pharmaceutical Products
, tested for treatment of progesterone sensitive myomata.
In 2005, Phase III trials were discontinued due to endometrial changes in patients. It is uncertain whether asoprisnil will be marketed.
Selective progesterone receptor modulator
A selective progesterone receptor modulator is an agent that acts on the progesterone receptor. A characteristic that distinguishes such substances from receptor full agonists and full antagonists is that their action differs in different tissues...
developed by Schering
Schering
Schering AG was a research-centered German pharmaceutical company. It was founded in 1851 by Ernst Christian Friedrich Schering and merged with Bayer's pharma sector in December 2006. The company's headquarters was in Berlin-Wedding, Germany...
and TAP Pharmaceutical Products
TAP Pharmaceutical Products
TAP Pharmaceutical Products was formed in 1977 as a joint venture between the two global pharmaceutical companies, Abbott Laboratories and Takeda Pharmaceutical Co. The company markets Prevacid and Lupron Depot , both leaders in their classes...
, tested for treatment of progesterone sensitive myomata.
In 2005, Phase III trials were discontinued due to endometrial changes in patients. It is uncertain whether asoprisnil will be marketed.